Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Tax Provisions (2021 - 2026)

Biohaven (BHVN) posted Tax Provisions of $272000.0 for Q1 2026, down 22.51% sequentially from $351000.0 in Q4 2025, and down 55.34% YoY from $609000.0 in Q1 2025.

Analysis

Biohaven (BHVN) Tax Provisions (2021 - 2026) Analysis & Trends

Biohaven has reported Tax Provisions for 6 years, with the latest figure at $272000.0 in Q1 2026.

  • Quarterly Tax Provisions fell 55.34% year-over-year to $272000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 42.58% YoY) and the FY2025 annual result came in at $1.4 million, up 96.19% from the prior year.
  • Tax Provisions declined to $272000.0 in Q1 2026 per BHVN's latest filing, from $351000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $7.3 million in Q1 2022 and troughed at -$14.1 million in Q4 2022.
  • A 5-year average of $88470.6 and a median of $272000.0 in 2026 frame the typical range for Tax Provisions.
  • The sharpest annual moves came in 2022 and 2025: Tax Provisions tumbled 675.62% in 2022, then surged 631.25% in 2025.
  • Over 5 years, Tax Provisions stood at -$14.1 million in 2022, then jumped by 91.43% to -$1.2 million in 2023, then soared by 103.96% to $48000.0 in 2024, then soared by 631.25% to $351000.0 in 2025, then decreased by 22.51% to $272000.0 in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods registered $272000.0, $351000.0, and $221000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -59.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.90 Mn
10 Biohaven 2.37 Bn 2.10 Bn - 391,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 391,000.00
Mar 31, 2026 272,000.00
Dec 31, 2025 351,000.00
Sep 30, 2025 221,000.00
Jun 30, 2025 261,000.00
Mar 31, 2025 609,000.00
Dec 31, 2024 48,000.00
Sep 30, 2024 -59,000.00
Jun 30, 2024 177,000.00
Mar 31, 2024 569,000.00
Dec 31, 2023 -1.21 Mn
Sep 30, 2023 -3.29 Mn
Jun 30, 2023 2.18 Mn
Mar 31, 2023 939,000.00
Dec 31, 2022 -14.14 Mn
Sep 30, 2022 1.22 Mn
Jun 30, 2022 6.11 Mn
Mar 31, 2022 7.26 Mn
Dec 31, 2021 2.46 Mn
Sep 30, 2021 -1.13 Mn